• Strategy
  • Payers
  • AI
  • Cybersecurity
  • Device Development
  • Studies/Published Research
  • Ethics
  • Regulatory
  • Digital Biomarkers
  • Data Science
  • Companion Diagnostics
  • Clinical Care
  • Digital Therapeutics
  • Academic Research
  • Virtual Reality
  • RWE
  • Digital Endpoints
  • Medical Devices (Class II and Class III)
  • Commercialization
  • Clinical Trials
  • Drug-Device Combinations
  • SaMD
  • Remote Patient Monitoring
  • Patient Engagement
  • Profiles/Q&A

AiCuris AG Appoints Larry Edwards as CEO

Article

Edwards took over the role on April 1, 2023.

AICuris Anti-infective Cures AG announced that Larry Edwards is the company's new CEO. He will also be president of AiCuris U.S. Inc., where he will be responsible for establishing the company's U.S. presence.

Former CEO Dr. Holger Zimmerman is moving to a new role as chief research and development officer.

Related Videos
Related Content
ImageCredit: Adobe Stock Images/dima_oris

Evergreen Theragnostics Raises $26M in Capital to Aid Commercialization Efforts for the Ga-68 DOTATOC Diagnostic Kit

April 17th 2024
Articles

Capital also expected to assist the advancement of Evergreen's radiopharmaceutical discovery pipeline into clinical trials.

Philips Respironics Finalizes Consent Decree Regarding Business Operations in the US with Department of Justice, FDA

Philips Respironics Finalizes Consent Decree Regarding Business Operations in the US with Department of Justice, FDA

April 10th 2024
Articles

Decree comes amid the FDA’s 2021 inspection of Philips’ Murrysville facility and the subsequent voluntary recall of its sleep and respiratory care devices.

FDA Approves Abbott’s i-STAT TBI Whole Blood Rapid Test to Assess Patients for Concussions at Bedside

FDA Approves Abbott’s i-STAT TBI Whole Blood Rapid Test to Assess Patients for Concussions at Bedside

April 2nd 2024
Articles

The concussion test, which shows results after 15 minutes, can help evaluate patients up to 24 hours after injury, company says.

FDA Approves Evolut TAVR System, Medtronic’s Treatment for Symptomatic Severe Aortic Stenosis

FDA Approves Evolut TAVR System, Medtronic’s Treatment for Symptomatic Severe Aortic Stenosis

March 28th 2024
Articles

Evolut FX+ transcatheter aortic valve replacement system design includes a larger coronary access window through a modified frame.

TNO Launches Peregrion, Aiming to Increase Market Presence of Accelerated Biomedical Mass Spectrometry Technology

TNO Launches Peregrion, Aiming to Increase Market Presence of Accelerated Biomedical Mass Spectrometry Technology

March 26th 2024
Articles

Spinoff seeks to aid pharmaceutical companies in accelerating early clinical development programs.

Use of AI Screening Tool for Cancer Expands Globally

Use of AI Screening Tool for Cancer Expands Globally

March 19th 2024
Articles

AI-powered radiology solutions can be used with both chest x-rays and breast cancer detection.

© 2024 MJH Life Sciences

All rights reserved.